Cannabigerol (CBG)

CBG - Cannabigerol

The Pharmacological Case for Cannabigerol

Rahul Nachnani, Wesley M. Raup-Konsavage, and Kent E. Vrana | Journal of Pharmacology and Experimental Therapeutics February 2021, 376 (2) 204-212 | Full Text
Colon Carcinogenesis cannabigerol

Benefits of VCE-003.2, a cannabigerol quinone derivative, against inflammation-driven neuronal deterioration in experimental Parkinson’s disease: possible involvement of different binding sites at the PPARγ receptor

Concepción García, María Gómez-Cañas, Sonia Burgaz, Belén Palomares, Yolanda Gómez-Gálvez, Cristina Palomo-Garo, Sara Campo, Joel Ferrer-Hernández, Carolina Pavicic, Carmen Navarrete, M. Luz Bellido, Moisés García-Arencibia, M. Ruth Pazos, Eduardo Muñoz, Javier Fernández-Ruiz | Journal of Neuroinflammation Volume 15, Article No: 19 (2018) | Full Text
Colon Carcinogenesis cannabigerol

Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabis-derived non-psychotropic cannabinoid

Francesca Borrelli, Ester Pagano, Barbara Romano, Stefania Panzera, Francesco Maiello, Diana Coppola, Luciano De Petrocellis, Lorena Buono, Pierangelo Orlando, Angelo A. Izzo | Carcinogenesis, Volume 35, Issue 12, December 2014 | Full Text
CBG Bowel Disease

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease

Francesca Borrellia, Ines Fasolino, Barbara Romano, Raffaele Capasso, Francesco Maiello, Diana Coppola, Pierangelo Orlando, Giovanni Battista, Ester Pagano, Vincenzo Di Marzo. Angelo A. Izzo | Biochemical Pharmacology Volume 85, Issue 9, 1 May 2013, Pages 1306-1316 | Full Text
CBG Alleviates Neuroinflammation

A Cannabigerol Quinone Alleviates Neuroinflammation in a Chronic Model of Multiple Sclerosis

Aitor G. Granja, Francisco Carrillo-Salinas, Alberto Pagani, María Gómez-Cañas, Roberto Negri, Carmen Navarrete, Miriam Mecha, Leyre Mestre, Bend L. Fiebich, Irene Cantarero, Marco A. Calzado, Maria L. Bellido, Javier Fernandez-Ruiz, Giovanni Appendino, Carmen Guaza, Eduardo Muñoz | Journal of Neuroimmune Pharmacology Volume 7, pages 1002–1016 (2012) | Full Text
CBG Multiple Sclerosis

Evidence that the plant cannabinoid cannabigerol is a highly potent α2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist

MG Cascio, LA Gauson, LA Stevenson, RA Ross, RG Pertwee | January 19, 2010 | British Journal of Pharmacology | Full Text
Wholesale CBG


Lost your password?

Create an account?

Subscribe for special offers

We will use the information you provide on this form to contact you and to provide updates and marketing. By clicking above to submit this form, you acknowledge that the information you provide will be processed in accordance with our Privacy Policy and Terms of Site Usage. You can unsubscribe from marketing anytime. For more details, review our Privacy Policy.

WordPress Cookie Notice by Real Cookie Banner